BioBridgeXAll companies

Sarepta Therapeutics, Inc.

Pharmaceutical company · Cambridge, Massachusetts, United States · Nasdaq: SRPT

Sarepta Therapeutics, Inc. is a pharmaceutical company headquartered in Cambridge, Massachusetts, United States. Its shares trade on Nasdaq under the ticker SRPT. The US FDA lists 1 drug manufacturing or testing site registered to the company. It has reported private securities offerings to the US SEC, most recently $400 million sold in a notice filed in 2020.

Profile compiled from public records. Is this your company? Request a correction or update

Sarepta Therapeutics at a glance

Typepharmaceutical company
HeadquartersCambridge, Massachusetts, United States
Stock listingNasdaq: SRPT
SEC industryPharmaceutical Preparations
FDA-registered sites1
SEC CIK873303

What does Sarepta Therapeutics do?

Operations at its FDA-registered drug sites

Analysis

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $400 million sold (2020).

Where is Sarepta Therapeutics located?

Headquarters: Cambridge, Massachusetts, United States

  • Andover, MassachusettsSarepta Therapeutics Inc · FDA drug site

Frequently asked questions about Sarepta Therapeutics

Where is Sarepta Therapeutics headquartered?

Sarepta Therapeutics, Inc. is headquartered in Cambridge, Massachusetts, United States.

What does Sarepta Therapeutics do?

Sarepta Therapeutics, Inc. is a pharmaceutical company. Its FDA-registered drug sites are registered for analysis. Its SEC industry classification is Pharmaceutical Preparations.

Is Sarepta Therapeutics a public company?

Yes. Sarepta Therapeutics, Inc. trades on Nasdaq under the ticker SRPT.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.